Sirona Biochem Corp
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company … Read more
Sirona Biochem Corp (SRBCF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of July 2024: 0.160x
Based on the latest financial reports, Sirona Biochem Corp (SRBCF) has a cash flow conversion efficiency ratio of 0.160x as of July 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-552.59K) by net assets ($-3.46 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sirona Biochem Corp - Cash Flow Conversion Efficiency Trend (2007–2023)
This chart illustrates how Sirona Biochem Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sirona Biochem Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sirona Biochem Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Inca Minerals Ltd
AU:ICG
|
-0.045x |
|
Tower One Wireless Corp
STU:1P3N
|
-0.544x |
|
Tokyo Plast International Limited
NSE:TOKYOPLAST
|
-0.028x |
|
TechCom Inc
PINK:TCRI
|
N/A |
|
Shuttle Pharmaceuticals Inc
NASDAQ:SHPH
|
-1.884x |
|
Kula Gold Ltd
AU:KGD
|
-0.204x |
|
Damodar Industries Limited
NSE:DAMODARIND
|
0.146x |
|
Diagnamed Holdings Corp.
PINK:DGNMF
|
0.150x |
Annual Cash Flow Conversion Efficiency for Sirona Biochem Corp (2007–2023)
The table below shows the annual cash flow conversion efficiency of Sirona Biochem Corp from 2007 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-10-31 | $-2.51 Million | $-1.76 Million | 0.700x | +106.89% |
| 2022-10-31 | $214.51K | $-2.18 Million | -10.151x | -145.63% |
| 2021-10-31 | $-97.02K | $-2.16 Million | 22.246x | +149.92% |
| 2020-10-31 | $47.40K | $-2.11 Million | -44.564x | -2641.24% |
| 2019-10-31 | $2.19 Million | $-3.56 Million | -1.626x | -662.19% |
| 2018-10-31 | $-2.26 Million | $-653.80K | 0.289x | -76.39% |
| 2017-10-31 | $-2.04 Million | $-2.50 Million | 1.225x | +191.01% |
| 2016-10-31 | $1.56 Million | $-2.10 Million | -1.346x | -22.27% |
| 2015-10-31 | $2.35 Million | $-2.58 Million | -1.100x | -5.93% |
| 2014-10-31 | $1.79 Million | $-1.86 Million | -1.039x | +10.78% |
| 2013-10-31 | $2.24 Million | $-2.61 Million | -1.164x | +7.70% |
| 2012-10-31 | $1.70 Million | $-2.14 Million | -1.261x | -35.27% |
| 2011-10-31 | $2.71 Million | $-2.52 Million | -0.933x | +24.30% |
| 2010-10-31 | $684.09K | $-842.70K | -1.232x | +48.67% |
| 2009-10-31 | $479.69K | $-1.15 Million | -2.400x | -2048.68% |
| 2008-10-31 | $1.03 Million | $-115.40K | -0.112x | -49.43% |
| 2007-10-31 | $1.13 Million | $-84.78K | -0.075x | -- |